Timeline comparison Who developed each compound and why it matters The corporate backing behind a pharmaceutical compound affects everything from clinical trial quality to eventual pricing and global availability
non-GLP-1RA Anti-diabetic medications The study first separately compared GLP-1RAs with each of the six classes of non-GLP-1RA anti-diabetic medications (SGLT2 inhibitors, metformin, sulfonylureas, thiazolidinediones, DPP-4 inhibitors, insulins)
What the research shows Several small-scale human studies show increases in blood and tissue glutathione following oral supplementation with liposomal glutathione, and recent research directly compared liposomal, micellar and standard glutathione (Prasad et al., 2026
Sigma-Aldrich, Cat#05-636) and Cyclin A (1:200
Glucose-tolerance and insulin-sensitivity measurements changed in obese mice
Advancing access to genome sequencing for rare genetic disorders: recent progress and call to action